I wonder why they cant get something happenong on the antimicrobials or whatever it was they were working on with genentech. Surely these would be a much quicker path to market and income, especially if they could unlock just 20% of the hinted milestones on the last deal. Surely much less trials required for that. Generate some income from there to fund the other research. This would show possibilities to earn cash and intent to progress the business to future investors. At the moment still just seems like they plan to keep ambling along researching whatever they fancy and hope someone takes an interest at some point. Surely at 2 billion shares now someone should consider or time to generate some income??
PYC Price at posting:
1.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)